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ABSTRACT 
Objective: To investigate the responsiveness to exercise therapy of patients with femoroacetabular 
impingement syndrome (FAIS), and differences in hip function, strength and morphology between 
responders vs. non-responders. 
Methods: Patients with FAIS underwent 12 weeks of semi-standardized and progressive exercise 
therapy. Good therapy outcome (responders) vs. poor therapy outcome (non-responders) was 
determined at week 18 with the Global Treatment Outcome for hip pain. Hip function was evaluated 
using the Hip Outcome Score (HOS) activities of daily living (ADL) and Sport at baseline, week 6, 12 
and 18. Hip muscle strength and dynamic pelvic control were evaluated using dynamometry and 
video analysis, respectively, at baseline, week 12 and 18. Hip morphology was evaluated with 
imaging at baseline. 
Results: Thirty-one patients (mean age: 24 years) were included. Sixteen (52%) patients were 
responsive and 15 (48%) were not responsive to exercise therapy. Only responders improved HOS 
ADL and HOS Sport by 10 (95% CI: 7 to 14, P<0.001) and 20 points (95%CI: 15 to 25, P<0.001), 
respectively, and hip abductor strength by 0.27 Nm/kg (95%CI: 0.18 to 0.36, P<0.001). The 
prevalence of patients showing good dynamic pelvic control only increased in responders (44%, 
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P=0.029). The prevalence of severe cam morphology was higher in non-responders than responders 
(40% vs. 6%, P=0.037). 
Conclusion: Half of patients with FAIS benefits from exercise therapy at short term. Responsiveness 
to hip abductor strength and dynamic pelvic control improvements is associated with good therapy 
outcome, whereas presence of severe cam morphology is associated with poor therapy outcome. 
Keywords: Femoroacetabular impingement syndrome; Exercise therapy; Pain; Muscle strength; 
Morphology 
 
SIGNIFICANCE AND INNOVATIONS 
• Some but not all patients with FAIS benefit at short term from exercise therapy; 
• The responsiveness to hip abductor strength and dynamic pelvis control improvements following 
therapy is associated with good exercise therapy outcome in patients with FAIS; 
• The presence of severe cam morphology is associated with poor exercise therapy outcome in 
patients with FAIS. 
 
Femoroacetabular impingement syndrome (FAIS) is a pathomechanism of the hip joint, which may 
cause debilitating hip pain in young adults and result in the development of hip osteoarthritis (OA) 
(1,2). FAIS is caused by abnormal morphology of the proximal femur and/or acetabulum, in 
conjunction with repetitive, rigorous and supraphysiological hip motion (1,3). Hip surgery has long 
been considered the main treatment option for FAIS, since the underlying pathomechanism is thought 
to be primarily caused by abnormal hip morphology (1). High-level evidence demonstrating the actual 
effectiveness of hip surgery for the management of FAIS is growing (4,5), but the best surgical 
indications are still subject of discussion (6). In contrast, non-surgical treatment options for FAIS 
have been largely overlooked (7), even if their failure should be the most important indication for 
surgery (7,8). In addition, valid non-surgical treatment options are required for those patients, who are 
not candidates for hip surgery (7,9). 
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Recently, a rationale has been proposed that explains how exercise therapy aimed at improving the 
neuromuscular function of the hip, trunk and lower limbs might be effective for the non-surgical 
management of FAIS (10). Dynamic hip instability due to hip muscle weakness (11,12) and impaired 
pelvic control (13-15) may lead to exaggerated mechanical loading of the acetabular labrum (16), and 
upregulation of its nociceptive receptors (17). Therefore, it was suggested that improving the dynamic 
stability of the femoroacetabular joint through exercise therapy aimed at improving hip muscle 
strength and pelvis control during functional tasks (14), may reduce the mechanical loading and 
contact stress on the joint structures, and in turn downregulate nociceptor activity (10). 
As the need to elucidate the effectiveness of non-surgical treatment protocols for FAIS, and to 
identify the characteristics of patients who can benefit from them (7) is of primary clinical relevance, 
the aims of this preliminary study were (i) to investigate the responsiveness of patients with FAIS to 
exercise therapy, and (ii) to evaluate the differences in hip function, hip muscle strength, dynamic 
pelvic control, as well as hip morphology and intra-articular damage patterns between patients 
responsive vs. non-responsive to exercise therapy. 
 
PATIENTS AND METHODS 
Study design 
Patients with FAIS underwent a 12-week semi-standardized and progressive exercise therapy 
program. Hip morphology and intra-articular damage were assessed with imaging at baseline. Hip 
pain, function and quality of life were evaluated with patient-reported questionnaires at baseline, 
week 6, 12 and 18. Hip muscle strength and dynamic pelvic control were respectively assessed with 
dynamometry and video analysis at baseline, week 12 and 18. The study was conducted according to 
the Declaration of Helsinki. The protocol was approved by the Ethics Committee of the Canton of 
Zurich, Switzerland and registered in ClinicalTrials.gov (trial registration number: NCT02368483). 
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Participants 
Patients were recruited by two expert hip surgeons (NAF, ML) from the Department of 
Orthopaedic Surgery, Schulthess Clinic, Zurich, Switzerland. The inclusion criteria were: 
diagnosis of FAIS based on symptoms, clinical examination and imaging findings (4), age 
between 18 and 35 years, no previous standardized non-surgical treatment, and no urgent 
indication for hip surgery based on surgeons’ opinion, such as early chondral degeneration in 
combination with severe cam morphology. Exclusion criteria were: previous hip surgery, 
surgery on the lower extremities in the last 6 months, hip dysplasia (lateral centre edge angle 
<20°) (18), hip osteoarthritis (Tönnis grade >1) (18), initiation of opioid analgesia or 
corticosteroid hip injections in the last 3 months, BMI >35 kg/m2 and cardiopulmonary 
diseases. All patients signed an informed consent before participating in the study. 
 
Intervention 
All patients received education from the respective hip surgeons, including advices on activity and 
lifestyle modifications (4). If needed, the use of oral analgesia including non-steroidal anti-
inflammatory drugs was permitted. The exercise therapy lasted 12 weeks and consisted of 4 
sessions/week (total of 48 sessions). Two face-to-face sessions/week were conducted at the 
Schulthess Clinic, Zurich, Switzerland under the supervision of a therapist (24 supervised sessions), 
and 2 sessions/week were conducted at home (24 home-based sessions). The semi-standardized 
protocol was aimed at improving dynamic hip joint stability with bilateral hip-specific and functional 
lower limb strengthening, core stability and postural balance exercises (10). The protocol consisted of 
3 phases (Phase I to III) with progressively increasing neuromuscular loading (Supplementary Table 
S1). Therapists were provided with a booklet including a list of exercises that could be used within 
each training phase and exercise type. Therapists had the freedom to design each session by choosing 
from among the exercises within each training phase and exercise type, based on the needs and 
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capacities of patients. Supervised sessions lasted 45 to 60 min and included a warm up, 4 hip-specific 
strengthening exercises, 2 functional lower limb strengthening exercises (except in Phase I), 2 core 
stability exercises, and 2 postural balance exercises. Home-based sessions lasted about 15 min and 
included a warm up, 1 hip abductor or extensor strengthening exercise, 1 functional lower limb 
strengthening exercise (except in Phase I), and 1 core stability exercise. Feedbacks for correct task 
execution and pelvic control were provided to patients after the performance of all exercises. The 
training volume for each exercise type was as follows: 1 series of 20 s for stretching exercises; 3 
series of 10-15 repetitions for isoinertial exercises; 3 series of 10-40 s for isometric exercises; 3 series 
of 30-60 s for postural balance exercises. Adherence to the intervention was controlled by asking 
therapists and patients to complete a protocol sheet after each supervised and home-based session, 
respectively. 
 
Assessments 
Therapy feasibility 
Patient eligibility and enrolment, therapy adherence (≥80% therapy session attendance), patients lost 
to follow-up, hip surgery rate until 1-year follow-up, and adverse event occurrence were reported. 
 
Therapy responsiveness 
Exercise therapy responsiveness was evaluated using the Global Treatment Outcome (GTO) for hip 
pain (19). The GTO is a single-item patient-reported questionnaire asking about changes in hip pain 
with respect to baseline. The five response options are: much better, better, somewhat better, 
unchanged, worse. Good outcome was achieved if patients reported hip pain to be much better or 
better, while poor outcome if hip pain was somewhat better, unchanged or worse at week 6, 12 and 18 
compared with baseline (20). The GTO at week 18 was used to categorize patients as responders 
(good therapy outcome) and non-responders (poor therapy outcome). Scales like the GTO are very 
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frequently used in clinical research with musculoskeletal patients to assess the significance of change 
following an intervention from the individual patient perspective (21). The GTO has been specifically 
used in patients with FAIS to evaluated changes following hip surgery (19,20), demonstrating good 
construct validity (20). 
 
Hip pain, function and quality of life 
Hip pain and function was evaluated using the Hip Outcome Score (HOS) (22). Two independent 
scores were obtained: one for activities of daily living (HOS ADL: 19 items, 17 scored) and one for 
sport activities (HOS Sport: 9 items, 9 scored). Health-related quality of life was evaluated using the 
Euro Quality of Life - Visual Analogue Scale (EQ-VAS) (23). The scores range from 0 to 100, where 
100 indicates the best possible score. 
 
Hip muscle strength 
Maximal voluntary isometric strength of the involved hip was evaluated with stabilized 
dynamometry (Nicholas Manual Muscle Tester, Lafayette Inc., Lafayette, IN, USA) for hip 
abductors, adductors, internal and external rotators, and with isokinetic dynamometry 
(Biodex System 4, Biodex Medical Systems, Shirley, New York, USA) for hip flexors and 
extensors. Test positions have been previously described elsewhere (11). For each muscle 
group, patients first completed 2 submaximal familiarization trials followed by 3-4 maximal 
trials. The rest interval between trials was 60 s. For each muscle group, the highest torque 
normalized to body mass was retained. 
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Dynamic pelvic control 
Dynamic pelvic control was evaluated with a visual rating scale during the execution of 2 challenging 
functional tasks: single-limb squat and hop lunge on the involved side (15,24). Standardized 
instructions for correct task execution were provided to the patients (15). Patients first completed 1-2 
familiarization trials followed by 4 recorded trials. Functional tasks were recorded using a video 
camera (Logitech HD Pro Webcam C920, Logitech, Lausanne, Switzerland), which was positioned 
frontal to the patient during the first 2 recorded trials and lateral to the patient during the second 2 
recorded trials (15). A highly-experienced physical therapist (MB) retrospectively analysed the videos 
and evaluated dynamic pelvic control using a segmental rating scale (15,24). The therapist evaluated 
if the pelvis dropped on the contralateral side in the frontal plane or rotated medially in the transversal 
plane maintaining the vertical body axis (pelvis 1), and if the pelvis moved away from the vertical 
body axis in the frontal plane (pelvis 2). For both pelvis 1 and 2, dynamic control was scored as 1 
(good pelvis control) or 0 (poor pelvis control). Average rating scores were retained. Acceptable intra-
rater agreement was observed for pelvic control rating as scored by a highly-experienced physical 
therapist, with mean agreement coefficients ranging between 0.74 to 0.67 for single-limb squat, and 
0.83 and 0.78 for single-limb hop lunge (15). 
 
Hip imaging 
The presence of cam morphology, acetabular labrum alterations and chondral damage in the involved 
hip were evaluated by two experienced radiologists (RS, CWP) with magnetic resonance imaging 
(MRI) arthrography (1.5 Tesla high-field system, Magnetom Avanto, Siemens Medical Solutions, 
Erlangen, Germany). Cam morphology was determined using the cam severity grading system and 
alpha angle. The cam severity grading is a semiquantitative scoring system that assesses the maximal 
offset at the head-neck junction on radial sequences (25). This grading system ranges from 0 to 3, 
where 0=normal, 1=possible deformity, 2=definite deformity, and 3=severe deformity. The alpha 
angle was measured on radial oblique MRI at the anterior, anterosuperior and superior segments (26). 
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The maximal alpha angle was retained. Acetabular labral alterations were evaluated on radial MRI as 
a linear band of high-signal intensity detected in the labrum (27). Chondral damage at the femoral 
head and acetabular cartilage was assessed with a semiquantitative grading scale (28). The presence of 
pincer morphology was assessed using the crossover sign on anteroposterior pelvic radiographs (29). 
In addition, the level of hip OA was evaluated on anteroposterior pelvic radiographs using the Tönnis 
grading system (18). 
 
Sample size 
Sample size was determined based on mean ± standard deviation changes in HOS ADL from baseline 
to 7-month follow up in patients responsive (22 ±18 points) vs. non-responsive (4 ± 7 points) to pain 
and function improvements following hip arthroscopy for FAIS (30). Considering an effect size of 
1.2, 5% type I error, 10% type II error, and 5% of patients lost to follow-up, a t test calculation 
indicated a sample size of 17 each group (34 in total). 
 
Data analysis 
Descriptive data are presented as mean ± standard deviation (continuous data) or as number and 
percentage (dichotomous data). Intention-to-treat analysis was performed including all patients who 
completed the assessments at week 6. For missing data, the "last observation carried forward" 
technique was used. Per-protocol analysis was performed including only those patients who 
completed the assessments at week 18. After controlling for assumptions, two-way ANCOVAs with 
repeated measures were used to evaluate changes in hip pain and function, quality of life and hip 
muscle strength (continuous data) at different times and differences between responders vs. non-
responders, while adjusting for baseline values. Fisher’s Least Significant Difference tests were used 
for post-hoc pairwise comparisons of the means. Fisher's Exact tests were used to evaluate changes in 
the proportion of patients with good dynamic pelvic control (dichotomous data) at different times and 
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differences between responders vs. non-responders. Baseline characteristics were compared between 
responders vs. non-responders using unpaired t tests (continuous data) and relative risks with Fisher’s 
Exact tests (dichotomous data). Changes, differences and relative risks were reported as means with 
95% confidence intervals. Minimal clinically important differences (MCID) of 8 points for HOS ADL 
(31), 14 points for HOS Sport (31), 15 points for EQ-VAS (20), and 10% for hip muscle strength 
were used for the interpretation of results. Statistical analyses were performed using PASW Statistics 
Version 18.0 (IBM Corporation, Armonk, NY). Significance level was set at P<0.05. 
 
RESULTS 
Therapy feasibility 
Sixty patients were eligible for the study between October 2014 and September 2016 (Figure 1). 
Thirty-four (57%) consecutive patients were enrolled in the study. Five patients (15%) were lost 
during the study: 3 before week 6 because of insufficient therapy adherence, and 2 between week 6 
and 12 because of injuries unrelated to the study. Eight patients (25%) had hip surgery: 3 between 
week 6 and 12, 2 between week 12 and 18, and 3 between week 18 and 1 year follow-up. Thirty-one 
patients had assessments at week 6 and were included in the intention-to-treat analysis. Twenty-four 
patients had assessments at week 18 and were included in the per-protocol analysis. All patients 
(100%) included in the analyses attended more than 80% of the therapy sessions. No adverse event 
was recorded. 
 
Therapy responsiveness 
A total of 3 (10%), 11 (35%) and 9 (29%) patients reported their hip pain to be much better, 12 
(39%), 10 (32%) and 7 (22%) better, 7 (22%), 5 (16%) and 6 (19%) somewhat better, 7 (22%), 3 
(10%) and 5 (16%) unchanged, and 2 (7%), 2 (7%) and 4 (14%) worse at week 6, 12 and 18, 
respectively, compared with baseline. A total of 15 (48%), 21 (68%) and 16 (52%) patients had good 
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outcome, that is, hip pain much better or better compared with baseline, at week 6, 12 and 18, 
respectively. Demographics, anthropometrics, physical examination outcomes and symptoms duration 
did not differ between responders vs. non-responders at baseline (Table 1). The prevalence of patients 
who were taking pain killer for hip symptoms at baseline was significantly higher in non-responders 
than responders (27% vs. 0%, P=0.043). 
 
Hip pain, function and quality of life 
HOS ADL and HOS Sport significantly improved and reached the respective MCID at week 12 and 
18 compared with baseline in responders, but not in non-responders (Table 2). Significantly larger 
increases in HOS ADL and HOS Sport were observed in responders vs. non-responders at week 18 
compared with baseline, achieving the respective MCID. EQ-VAS significantly improved and 
approached the MCID at week 12 and 18 compared with baseline in responders, but not in non-
responders. Significantly larger increase in EQ-VAS was observed in responders vs. non-responders 
at week 18 compared with baseline, approaching the MCID. 
 
Hip muscle strength 
Strength of all hip muscle groups significantly improved and reached the MCID at week 12 and 18 
compared with baseline in responders (Table 3). Strength of hip internal rotators, external rotators and 
flexors, but not of the other hip muscle groups, significantly increased and achieved the MCID at 
week 12 and 18 compared with baseline in non-responders. Significantly larger increase in hip 
abductor strength was observed in responders vs. non-responders at week 12 and 18 compared with 
baseline, reaching the MCID. 
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Dynamic pelvic control 
The prevalence of patients performing the single-limb squat with good dynamic pelvis 2 control 
significantly increased at week 18 compared with baseline in responders (19% to 63%. P=0.029), but 
not in non-responders (Table 4). 
 
Hip imaging 
The prevalence of patients with cam severity grade 3 was significantly higher in non-responders than 
in responders (40% vs. 6%, P=0.037, Table 5). The mean ± SD alpha angle was 73 ± 6° in patients 
with cam severity grade 3, 68 ± 5° with grade 2, 60 ± 3° with grade 1 and 54 ± 2° with grade 0. The 
prevalence of pincer morphology and intra-articular damage did not differ significantly between 
responders vs. non-responders. All patients had Tönnis grade 0. 
 
Per-protocol analysis 
Results of per-protocol analysis were comparable with those of intention-to-treat analysis 
(Supplementary Tables S2-S6). In contrast with intention-to-treat analysis, HOS ADL and HOS Sport 
significantly improved and reached the respective MCID in non-responders at week 12 compared 
with baseline, and change in HOS Sport did not differ in responders vs. non-responders at week 18 
compared with baseline. Moreover, change in hip abductor strength did not differ in responders vs. 
non-responders at week 18 compared with baseline. 
 
DISCUSSION 
In this preliminary study, half of the patients with FAIS did benefit at short-term follow-up from 12 
weeks of semi-standardized and progressive exercise therapy. Responders improved their hip function 
during ADL and sport activities, hip abductor strength and pelvic control in the frontal plane during 
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single-limb squat, whereas non-responders did not. In addition, the large majority of patients with 
severe cam morphology were not responsive to exercise therapy. 
 
Strengths and limitations 
To our knowledge, this is the first study that evaluates differences in hip function, strength and 
morphology between responders vs. non-responders to exercise therapy for FAIS. The identification 
of patient characteristics, which may predict the success vs. failure of exercise therapy, is of interest 
in orthopaedics and sport medicine to provide valid non-surgical treatment options and strengthen 
surgical indications (7). The main limitation of this study is the absence of a control group. At the 
time of study planning, we could not find an ethically and methodologically valid control treatment to 
compare the outcomes of exercise therapy. Thus, we decided to treat all patients with exercise 
therapy, and retrospectively analyse differences between responders and non-responders. In addition, 
a patient-reported outcome, that is, the GTO for hip pain, was used to categorize patients as 
responders vs. non-responders. An objective measure, such as hip cartilage health assessed using MRI 
arthrography, could be used to avoid subjective bias (32), since treatments for FAIS should aim at 
reducing pain, but also at decelerating the hip degenerative process (4). However, hip joint 
degeneration changes were not expected in this study because of the short-term follow-up. Future 
studies with longer follow-ups should evaluate if exercise therapy might decelerate the degenerative 
process of the hip joint in patients with FAIS, preventing the development of hip OA. Moreover, 
differences in hip function, strength and morphology changes following exercise therapy were not 
evaluated between female and male patients. Since we found no sex-difference in exercise therapy 
responsiveness (Table 1), sex was not used as covariate in our analyses. In addition, the small sample 
size did not allow us to use sex as a main factor in our analyses. Future larger studies should however 
consider sex-differences for exercise therapy effectiveness due to different clinical (33) and functional 
characteristics (13,34) presented by female and male patients with FAIS. 
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Therapy responsiveness 
The responsiveness to exercise therapy found in our study (52%) was similar or better compared with 
that observed in earlier studies (35,36), and similar to the outcomes reported for hip surgery for FAIS 
at short-term follow-up (20). Hunt et al observed that only 33% of their patients with FAIS could 
benefit from a trial of exercise therapy (35), while Wright et al and Impellizzeri et al had 60% of their 
patients reporting good outcomes after 6 weeks of exercise therapy, and at 6 months after hip surgery, 
respectively (20,36). The relatively poor outcomes reported by Hunt et al may be the result of the low 
and variable amount of therapy provided to the patients (i.e., mean of 6 sessions, range: 1 to 19) (35). 
In the present study, 8 patients (25%) decided to have hip surgery, as controlled until 1 year follow-
up. All of them had a poor outcome at the last available follow-up, with 4 patients reporting their hip 
pain to be worse, 3 unchanged, and 1 somewhat better compared with baseline. These patients 
generally reported lower hip function and strength outcomes compared with other non-responders, as 
confirmed by the per-protocol analysis, in which only the best non-responders were included. Indeed, 
larger improvements in hip function and strength were observed for non-responders in the per-
protocol than intention-to-treat analysis, resulting in less differences compared with responders. The 
observed surgery rate was lower than in earlier studies (53% to 65%) (35,36). The level of symptoms 
and hip joint degeneration may explain the higher surgery rates in previous studies, with patients 
being on average older than our patients (34 vs. 24 years) (35,36), having more hip pain and worse 
hip function (36), and most of them being already considered for surgery at baseline (35,36). 
 
Dynamic hip joint stability 
The responsiveness to improvements in hip abductor strength and dynamic pelvic control while 
performing a single-limb squat was associated with good therapy outcomes. These results strengthen 
the rationale that an improved dynamic stability of the femoroacetabular joint may reduce the 
mechanical load on the acetabular labrum, resulting in a reduction of symptoms (10). In particular, hip 
abductor muscles seem to be determinant for achieving a good dynamic pelvic control (15,37), and 
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femoroacetabular joint stability (38). Nevertheless, future research needs to confirm these 
observations by investigating the effects of hip muscle strength and pain changes following exercise 
therapy on hip joint kinematics, loadings and contact stresses using motion analysis, musculoskeletal 
and finite element modelling, respectively. In addition, exercise therapy shorter than 12 weeks, as 
well as therapy discontinuation after 12 weeks of training, might be associated with poor therapy 
outcomes. Indeed, the prevalence of patients with good outcome increased from 48% after 6 weeks to 
68% after 12 weeks of therapy. Moreover, patients with good outcome did not achieve a clinically 
relevant improvement in hip pain and function before 12 weeks of therapy. We speculate that 6 weeks 
of therapy are not enough to induce the neuromuscular adaptations responsible for dynamic hip 
stability improvements and symptoms reduction (39). In addition, the prevalence of patients with a 
good outcome decreased from 68% after 12 weeks of therapy to 52% at follow-up 6 weeks later. We 
assume that the worsening of symptoms in some patients may be the result of insufficient training 
stimuli after completion of supervised therapy, not enabling to preserve the achieved benefits. 
 
Cam morphology 
The presence of severe cam morphology seems to predict the failure of exercise therapy. In our study, 
a total of 7 patients (23%) presented with severe cam morphology: 6 were not responsive while only 1 
was responsive to exercise therapy. We assume that large morphological abnormalities at the 
proximal femur do not allow to improve the hip neuromuscular function and dynamic hip stability 
following exercise therapy, so as to reduce the symptoms. In our study, severe cam deformities 
corresponded to an alpha angle of 73 ± 6°. There is increasing evidence that patients with an alpha 
angle >78° present a high risk to develop hip OA (40). Taken together, these findings suggest that 
patients with severe cam morphology are probably not the best candidates for non-surgical treatment 
options, but rather for hip surgery. 
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Conclusions 
Half of patients with FAIS benefits at short term follow-up from exercise therapy by experiencing a 
clinically relevant hip pain reduction. Responsiveness to improvements in hip function, hip abductor 
strength and dynamic pelvic control is associated with a good therapy outcome. In contrast, the 
presence of severe cam morphology is associated with a poor therapy outcome. Future randomised 
controlled trials comparing exercise therapy with a control treatment (e.g., passive physical therapy) 
should be conducted to confirm these preliminary results. 
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FIGURE LEGENDS 
Figure 1. Study flowchart  
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Table 1. Patients' characteristics at baseline 
 Mean ± SD / Number (%) Mean difference (95% CI)/ 
Relative risk (95% CI) 
 
All Responders Non-responders
Demographics  
Gender (women) 20 (65) 11 (69) 9 (60) 1.21 (0.57 - 2.58) 
Age (years) 25 ± 5  24 ± 5 25 ± 5 1 (-3 - 4) 
Anthropometrics      
Body mass (kg) 68 ± 12  65 ± 13 70 ± 11 5 (-4 - 14) 
Height (cm) 172 ± 9 170 ± 9 173 ± 8 3 (-4 - 9) 
BMI (kg/m2) 23 ± 4 22 ± 4 23 ± 3 1 (-1 - 4) 
Provocation tests (positive)      
FADIR test 29 (94)  16 (100) 13 (87) 2.23 (1.49 - 3.34) 
FABER test 19 (61)  12 (75) 7 (47) 1.81 (0.89 - 3.69) 
Posterior impingement test 17 (55) 10 (63) 7 (47) 1.39 (0.67 - 2.87) 
Range of motion (°)  
Hip flexion 103 ± 12  101 ± 11 104 ± 14 3 (-6 - 12) 
Hip internal rotation 25 ± 10  25 ± 11 24 ± 10 -1 (-8 - 7) 
Hip abduction 35 ± 5  35 ± 5 35 ± 5 0 (-4 - 3) 
Symptoms duration (months) 40 ± 36 37 ± 32 41 ± 36 4 (-20 - 29) 
Contralateral hip pain 13 (42) 5 (31) 8 (53) 0.63 (0.31 - 1.30) 
Pain killer intake 4 (13)  0 (0) 4 (27) 0.41* (0.26 - 0.64) 
BMI, body mass index; FADIR, flexion-adduction-internal rotation; FABER, flexion-abduction-
external rotation; CI, confidence interval. Mean ± SD and differences are reported for continuous 
data; numbers, percentages and relative risks are reported for dichotomous data. * indicates 
significant difference at P<0.05. Responders, n=16; non-responders, n=15. 
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Table 2. Hip pain, function and quality of life 
 Scores by week 
Mean ± SD 
 Score changes within group 
Mean (95% CI) 
 Score differences between 
groups 
Mean (95% CI) 
 0 6 12 18 Week 6 Week 
12 
Week 
18 
Week 
6 
Week 
12 
Week 
18 
HOS ADL (0 
to 100) 
            
Responders 85 
± 9 
91 
± 6 
95 
± 7 
95 
± 6 
 6*** (3 - 
10) 
10*** (7 
- 14) 
10*** (7 
- 14) 
 4 (-1 - 
11) 
5 (-1 - 
11) 
10** (5 
- 17) 
Non-
responders 
80 
± 
18 
82 
± 
19 
85 
± 
17 
80 
± 
22 
2 (-2 -
5) 
5** (1 -
9) 
0 (-4 -
3) 
  
HOS Sport (0 
to 100) 
            
Responders 71 
± 
17 
82 
± 
15 
90 
± 
12 
91 
± 
10 
11*** (6 
- 16) 
19***
(14 - 
24) 
20***
(15 - 
25) 
8 (0 - 
16) 
10* (2 - 
18) 
14** (6 
- 22) 
Non-
responders 
68 
± 
24 
71 
± 
22 
77 
± 
22 
74 
± 
23 
 3 (-2 - 
8) 
9*** (4 - 
14) 
6* (1 - 
11) 
    
EQ-VAS (0 to 
100) 
            
Responders 78 
± 
11 
87 
± 
10 
91 
± 7 
91 
± 9 
 9*** (4 - 
13) 
13*** (8 
- 17) 
13*** (8 
- 17) 
 4 (-4 - 
10) 
8* (1 - 
14) 
13** (5 
- 19) 
Non-
responders 
75 
± 
16 
80 
± 
14 
80 
± 
13 
75 
± 
12 
 5* (1 - 
10) 
5* (1 - 
10) 
0 (-4 - 
5) 
    
HOS, Hip Outcome Score; ADL, activities of daily living; EQ-VAS, EuroQol-Visual Analogue Scale; 
CI, confidence interval. *, ** and *** indicate significant difference at P<0.05, P<0.01 and P<0.001, 
respectively. Responders, n=16; non-responders, n=15. 
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Table 3. Hip muscle strength 
Hip muscle group Muscle strength (Nm/kg) 
 
Scores by week 
Mean ± SD 
 Score changes within 
group 
Mean (95% CI) / % 
 Score differences between 
groups 
Mean (95% CI) / % 
 0 12 18  Week 12 Week 18  Week 12 Week 18 
Adductors          
Responders 2.29 
± 
0.61 
2.73 
± 
0.84 
2.62 
± 
0.79 
 0.44*** 
(0.27 - 
0.61)/19 
0.33*** 
(0.16 - 
0.50)/14 
 0.38** (0.11 
- 0.64)/17 
0.22 (-0.04 
- 0.48)/11 
Non-responders 2.48 
± 
0.69 
2.54 
± 
0.62 
2.59 
± 
0.76 
 0.06 (-0.11 
- 0.24)/2 
0.11 (-0.06 
- 0.29)/4 
   
Abductors     
Responders 1.80 
± 
0.41 
2.07 
± 
0.40 
2.07 
± 
0.36 
0.27***
(0.18 - 
0.36)/15 
0.27***
(0.18 - 
0.36)/15 
0.20** (0.07 
- 0.32)/11 
0.17* (0.04 
- 0.30)/10 
Non-responders 1.86 
± 
0.45 
1.93 
± 
0.43 
1.96 
± 
0.49 
0.07 (0.02 -
0.16)/4 
0.10* (0.01 
- 0.19)/5 
 
Internal rotators          
Responders 0.74 
± 
0.25 
0.96 
± 
0.20 
0.88 
± 
0.18 
 0.22*** 
(0.14 - 
0.29)/30 
0.14** (0.06 
- 0.21)/19 
 0.09 (-0.02 
- 0.19)/13 
0.00 (-0.11 
- 0.11)/1 
Non-responders 0.76 
± 
0.34 
0.89 
± 
0.29 
0.90 
± 
0.29 
 0.13** (0.06 
- 0.21)/17 
0.14** (0.06 
- 0.21)/18 
   
External rotators     
Responders 0.53 
± 
0.20 
0.68 
± 
0.15 
0.63 
± 
0.15 
0.15***
(0.10 - 
0.21)/28 
0.10***
(0.05 - 
0.16)/19 
0.04 (-0.04 
- 0.13)/8 
-0.02 (-0.11 
- 0.07)/-2 
Non-responders 0.56 
± 
0.24 
0.67 
± 
0.22 
0.68 
± 
0.25 
 0.11*** 
(0.05 - 
0.16)/20 
0.12*** 
(0.06 - 
0.17)/21 
   
 
         
Flexors          
Responders 1.31 
± 
0.45 
1.51 
± 
0.46 
1.50 
± 
0.39 
 0.20*** 
(0.12 - 
0.28)/15 
0.19*** 
(0.11 - 
0.27)/14 
 0.03 (-0.10 
- 0.17)/2 
0.03 (-0.10 
- 0.17)/2 
Non-responders 1.36 
± 
0.31 
1.53 
± 
0.37 
1.52 
± 
0.41 
 0.17*** 
(0.08 - 
0.25)/13 
0.16*** 
(0.07 - 
0.24)/12 
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Extensors     
Responders 2.24 
± 
0.61 
2.70 
± 
0.77 
2.47 
± 
0.64 
 0.46*** 
(0.25 - 
0.66)/20 
0.23* (0.02 
- 0.44)/10 
 0.32 (-0.03 
- 0.67)/14 
0.04 (-0.31 
- 0.39)/2 
Non-responders 2.40 
± 
0.83 
2.54 
± 
0.72 
2.59 
± 
0.76 
0.14 (-0.08 
- 0.35)/6 
0.19 (-0.02 
- 0.41)/8 
 
CI, confidence interval. *, ** and *** indicate significant difference at P<0.05, P<0.01 and P<0.001, 
respectively. Responders, n=16; non-responders, n=15. 
 
Table 4. Dynamic pelvic control 
 Good performers 
Number (%) 
Good performer changes 
within group 
Number (%) 
Good performer differences 
between groups 
Number (%) 
 
0 12 18 Week 12 Week 18 Week 12 Week 18 
Single-limb 
squat 
    
Pelvis 1          
Responders 4 
(25) 
8 
(50) 
8 
(50) 
 4 (25) 4 (25)  3 (18) 2 (12) 
Non-responders 3 
(20) 
4 
(27) 
5 
(33) 
1 (7) 2 (13)  
Pelvis 2          
Responders 3 
(19) 
9 
(56) 
10 
(63) 
 6 (37) 7* (44)  5 (31) 5 (31) 
Non-responders 4 
(27) 
5 
(33) 
6 
(40) 
1 (6) 2 (13)  
Single-limb hop 
lunge 
         
Pelvis 1          
Responders 2 
(13) 
4 
(25) 
5 
(31) 
2 (12) 3 (18) 0 (0) 1 (5) 
Non-responders 3 
(20) 
5 
(33) 
5 
(33) 
 2 (13) 2 (13)    
Pelvis 2          
Responders 2 
(13) 
4 
(25) 
5 
(31) 
2 (12) 3 (18) 0 (0) 1 (5) 
Non-responders 3 
(20) 
5 
(33) 
5 
(33) 
 2 (13) 2 (13) 
13) 
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Pelvis 1, pelvis moves out of neutral in the frontal or transversal plane; Pelvis 2, pelvis moves away 
from midline; CI, confidence interval. * indicates significant difference at P<0.05. Responders, n=16; 
non-responders, n=15. 
 
Table 5. Hip morphology and intra-articular damage patterns 
 Number (%) Relative risk (95% CI) 
 
Responders Non-responders  
Cam severity grade    
Grade 3 1 (6) 6 (40) 0.44* (0.24 - 0.80) 
Grade 2 11 (69) 7 (47) 1.58 (0.77 - 3.25) 
Grade 1 2 (12) 1 (7) 1.50 (0.29 - 7.75) 
Grade 0 2 (12) 1 (7) 1.50 (0.29 - 7.75) 
Crossover sign 13 (81) 14 (93) 0.48 (0.08 - 2.74) 
Acetabular labral tear 13 (81) 13 (87) 0.80 (0.26 - 2.50) 
Cartilage damage  
Acetabulum 3 (19) 6 (40) 0.61 (0.31 - 1.21) 
Femur 3 (19) 2 (13) 1.25 (0.40 - 3.91) 
CI, confidence interval. * indicates significant difference at P<0.05. Responders, n=16; non-
responders, n=15. 
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